SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) srt2:(2000-2004)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Cancer och onkologi) > (2000-2004)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
61.
  • Fernandes, Oswaldo J. C. B., et al. (författare)
  • Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer
  • 2003
  • Ingår i: Acta Oncologica. - Oslo, Norway : Taylor & Francis. - 0284-186X. ; 42:4, s. 338-341
  • Tidskriftsartikel (refereegranskat)abstract
    • The survival and outcome rates of 284 patients who underwent surgical treatment for non-small cell lung cancer were assessed retrospectively. Resectability rate was 94.1%, hospital mortality 3.9% (n = 11) and the mortality rates in patients who underwent pneumonectomy or lobectomy were 8.9% and 0.6%, respectively. The overall 5-year survival was 43.6%. Female gender, earlier stages of disease and a complete resection were strongly predictive for a long-term survival. Women in stage IA disease had a 5-year survival rate of 92.7%. The 5-year survival rate for patients in stages IIIA and N2 disease who underwent a complete resection was 21.9%, and 9% for those who did not undergo a complete resection. It is concluded that the best surgical results were observed in women who were operated on at an early stage of disease. A complete resection also contributed to a better outcome, even for patients in stage IIIA and N2 disease.
  •  
62.
  • Graflund, Marianne, et al. (författare)
  • Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma : correlation with clinical outcome
  • 2002
  • Ingår i: International Journal of Gynecological Cancer. - Malden, USA : Blackwell Publishing. - 1048-891X .- 1525-1438. ; 12:3, s. 290-298
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The objective of this study was to assess the value of p53, bcl-2, and p21(WAF1/CIP1) immunoreactivity as predictors of pelvic lymph node metastases (LNM), recurrences, and death due to the disease in early stage (FIGO I-II) cervical carcinomas. FIGO stage, type of histopathology, and tumor grade were also evaluated in this series of patients treated by radical hysterectomy (Wertheim-Meigs) between 1965 and 1990. A total of 172 patients were included. A tumor was regarded as positive when more than 30% of the neoplastic cells exhibited immunoreactivity. Positive immunostaining was found in 8.9% for p53, in 43.5% for bcl-2, and in 25.0% for p21(WAF1/CIP1). None of them was able to predict LNM or clinical outcome. Presence of LNM, tumor recurrence, and death from disease were significantly associated with the FIGO stage (P = 0.014, P = 0.009, and P = 0.001, respectively). The 5-year cancer-specific survival rate was 91.6% and the overall survival rate was 90.5%. It was concluded that immunohistochemically detected p53, bcl-2, and p21(WAF1/CIP1) appeared to be of no predictive value with regard to LNM, tumor recurrences, or long-term survival in early cervical carcinomas.</p>
  •  
63.
  • Graflund, Marianne, et al. (författare)
  • MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas : correlation with clinical outcome
  • 2002
  • Ingår i: International Journal of Oncology. - Athens, Greece : Spandidos Publications. - 1019-6439. ; 20:5, s. 1041-1047
  • Tidskriftsartikel (refereegranskat)abstract
    • A complete series of 40 cervical carcinomas with pelvic lymph node metastases were analysed immunohistochemically for prognostic markers. The aims of this study were to examine whether the detection of MIB-1, p53, bcl-2, and WAF-1 could be used as a prognostic marker for tumor recurrence and survival rate. During the period of observation (mean 222, range 72-360 months) 22 (55%) recurrences were encountered and 20 patients died of the disease. There were 35 squamous cell carcinomas (87.5%), 2 adenosquamous carcinomas (5.0%), and 3 pure adenocarcinomas (7.5%). One tumor (2.5%) was well differentiated, 12 tumors (30%) were moderately differentiated, and 27 tumors (67.5%) were poorly differentiated. The primary tumor grade (P=0.037) and radicality of the surgical margins (P=0.021) were significant prognostic factors with regard to tumor recurrence. The site and number of lymph nodes with metastases had no prognostic value. P53, bcl-2, and WAF-1 were not predictive factors for recurrences or the cancer-specific survival rate. The concordant expression of WAF-1 in the primary tumor and in lymph node metastases was lower than for p53 and bcl-2. The proliferative activity (MIB-1) seemed to be lower in tumor cells metastasized to the pelvic lymph nodes than in cells of the primary tumor. Expression of MIB-1 in lymph nodes was predictive of disease-free survival in both univariate and multivariate proportional hazard Cox analyses.
  •  
64.
  • Graflund, M., et al. (författare)
  • Relation between HPV-DNA and expression of p53, bcl-2, p21WAF-1, MIB-1, HER-2/neu and DNA ploidy in early cervical carcinoma : correlation with clinical outcome
  • 2004
  • Ingår i: Oncology Reports. - Athens, Greece : Spandidos Publications. - 1021-335X. ; 12:1, s. 169-176
  • Tidskriftsartikel (refereegranskat)abstract
    • The purpose of the present study was to analyze the relation between the expression of p53, bcl-2, p21WAF1, MIB-1, HER-2/neu, DNA ploidy and HPV16 or 18 infections with clinical parameters. HPV-DNA was evaluated in 171 early cervical carcinomas treated from 1965 to 1990 and detected by PCR (polymerase chain reaction) on paraffin specimens obtained before therapy was started. HPV-DNA of any type was detected in 78% (86/110) of all tumors, HPV16 was the predominant type and was seen in 56% (62/110), HPV18 in 8% (9/110) and HPV35 in 21% (23/110). Patients with HPV16 or 18 were significantly (P=0.011) younger than patients with tumors not containing these two HPV subtypes. Lymph node metastases were seen more frequently (P=0.047) in tumors expressing HPV16 or 18. Tumor size was associated with the HPV-type. The frequency of DNA aneuploidy was lower in high-risk HPV tumors than in tumors with other HPV subtypes (P=0.014). MIB-1 expression was highly significantly (P=0.00007) associated with presence of HPV16 or 18. The cancer-specific survival rate was lower for patients with HPV16 and 18 positive tumors, but the difference was not statistically significant. The overall 5-year survival rate of the complete series was 91%. In conclusion, the HPV DNA subtype was a prognostic factor in early stage cervical cancer and it was associated with age, positive lymph nodes, tumor size, DNA ploidy and the proliferation marker MIB-1.
  •  
65.
  • Graflund, Marianne, et al. (författare)
  • The prognostic value of a histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas
  • 2002
  • Ingår i: International Journal of Gynecological Cancer. - Malden, USA : Blackwell Publishing. - 1048-891X. ; 12:2, s. 149-157
  • Tidskriftsartikel (refereegranskat)abstract
    • This study evaluated the prognostic importance of a new grading system focusing on the invasive tumor front, DNA profile, and the proliferation marker MIB-1. A complete geographic series of 172 women treated with radical hysterectomy (Wertheim-Meigs) for FIGO stage I-II cervical carcinomas was the target population. The analyses were performed on 141 (82%) squamous cell carcinomas of the complete series. During the period of observation (mean 222 months), 17 recurrences (12.1%) were encountered. Prognostic factors for disease-free survival were lymph node status (P &lt; 0.000001), radical surgical margins (P = 0.00004), and tumor size (P = 0.002). The complete score of the invasive front grading system (IFG), and the individual scores of two variables-pattern of invasion and host response-were all significantly (P = 0.002, P = 0.007, P = 0.0001) associated with pelvic lymph node metastases. Host response was the single most important factor in the IFG system, and it was superior to the complete score in predicting lymph node metastases. The total IFG score was also a significant (P = 0.003) prognostic factor for disease-free survival. DNA ploidy, S-phase fraction, and MIB-1 expression were nonsignificant factors in predicting pelvic lymph node metastases and disease-free survival of the patient. The IFG in the original or modified versions could predict low- and high-risk groups of tumors and therefore be of value in treatment planning for these patients.
  •  
66.
  • Graflund, Marianne, et al. (författare)
  • The prognostic value of histopathologic grading parameters and microvessel density in patients with early squamous cell carcinoma of the uterine cervix
  • 2002
  • Ingår i: International Journal of Gynecological Cancer. - Malden, USA : Blackwell Publishing. - 1048-891X. ; 12:1, s. 32-41
  • Tidskriftsartikel (refereegranskat)abstract
    • The purpose of this study was to investigate the prognostic importance of clinical and histopathologic factors, including malignancy grading systems (MGS), partial index (PI), invasive front grading (IFG), and microvessel density. A complete geographic series of 172 early stage (FIGO I-II) cervical carcinomas treated by Wertheim-Meigs surgery during the period 1965-1990 was studied. The patients were followed up for at least 10 years. Significant prognostic factors for disease-free survival were lymph node status (P &lt; 0.0000001), radical surgical margins (P = 0.00003), and tumor size (P = 0.008). In a multivariate Cox analysis it was shown that lymph node status was the single most important prognostic factor with regard to disease-free survival. The total MGS and the PI scores were highly significantly (P = 0.0001) associated with pelvic lymph node metastases and disease-free survival rate in squamous cell carcinomas. The MGS and the PI systems were superior to the IFG system in predicting lymph node metastases. The total IFG score was also a statistically highly significant (P = 0.003) prognostic factor with regard to disease-free survival in both univariate and multivariate analyses. Microvessel density was a nonsignificant prognostic factor. There was a highly significant (P = 0.002) association between vascular space invasion of tumor cells and the presence of lymph node metastases. In conclusion, histopathologic malignancy grading systems provide valuable prognostic information in patients with early stage squamous cell carcinomas of the uterine cervix.
  •  
67.
  • Li, Hui-xiang, et al. (författare)
  • [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis]
  • 2004
  • Ingår i: Zhonghua zhong liu za zhi [Chinese journal of oncology]. - Beijing, China : Zhongguo Yixue Kexueyuan / Cancer Hospital, Chinese Academy of Medical Sciences. - 0253-3766. ; 26:11, s. 669-672
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: To study the expression of thymidine phosphorylase (TP), thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA in breast cancer and its correlation with prognosis.Methods: Expression levels of TP, TS and DPD mRNA in 86 micro-selected breast cancer tissues and 9 normal breast tissues were detected by real-time quantitative PCR.Results: The median expression levels of TP, TS and DPD mRNA in tumor tissue and in normal tissues were 16.54, 0.38, 2.47 and 11.75, 0.25, 8.33, respectively, there were no significant differences (P &gt;0.05). The expression levels of TP, TS and DPD mRNA showed no association with tumor size, lymph node metastasis, pathological grade and clinical stage, except that of DPD showed a negative association with patients' ages. There was no significant difference in disease-free survival or overall survival between the patients with high and low TP or DPD mRNA levels. Disease-free survival tends to be better in the patients with low TS mRNA level than those with high TS mRNA, but the difference was not significant (P=0.069), while the overall survival showed a statistically difference (59.00 month and 70.30 month) (P=0.0496).Conclusion: The expression level of TS mRNA may serve as a prognostic marker for breast cancer patients.
68.
  • Suo, Zhenhe, et al. (författare)
  • The expression of EGFR family ligands in breast carcinomas
  • 2002
  • Ingår i: International Journal of Surgical Pathology. - Thousand Oaks, USA : Sage Publications. - 1066-8969. ; 10:2, s. 91-99
  • Tidskriftsartikel (refereegranskat)abstract
    • Expression of EGF, HB-EGF, TGF-alpha, HRG-alpha, HRG-beta1, and HRG-beta3 in 100 frozen breast carcinoma materials was immunohistochemically studied. Among these tumors, 67% were positive for EGF, 53% for HB-EGF, 57% for TGF-alpha, 60% for HRG-alpha, 53% for HRG-beta1, and 63% for HRG-beta3 in the neoplastic epithelial cells. No significant associations between expression of the growth factors and clinicopathological features like tumor size, histologic grade, node status, ploidy, ER status, and c-erbB-4 expression were observed, with the exceptions that significant relations were present between EGF expression and tumor size (p = 0.01) and between HRG-beta3 expression and node status (p = 0.02). The expressions of these growth factors showed no association with cancer-specific survival by the Kaplan Meier analysis.
  •  
69.
  • Uggla, Bertil, 1962-, et al. (författare)
  • Expression of topoisomerase IIalpha in the G0/G1 cell cycle phase of fresh leukemic cells
  • 2001
  • Ingår i: Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis. - Oxford, United Kingdom : Elsevier. - 0145-2126. ; 25:11, s. 961-966
  • Tidskriftsartikel (refereegranskat)abstract
    • Topoisomerase IIalpha (topoII alpha) is the target enzyme for several antineoplastic drugs. Correlation between low expression of topo IIalpha and drug resistance has been shown in vitro, but there is limited evidence of a correlation to initial response to treatment or to overall prognosis. Normal cells express topo IIalpha in S/G2/M phase of the cell cycle but not in G0/G1 phase. However, some data suggest that topo IIalpha could be expressed in G0/G1 phase in malignant cells. We have investigated the expression of topo IIalpha in leukemic cells from 25 patients with acute leukemia by flow cytometry, separating cells of different cell cycle phases. We demonstrated that 9/25 samples showed &gt;50% positive cells in G0/G1, and another five samples showed &gt;20%. This finding could possibly provide an explanation to previous difficulties in correlating topo IIalpha expression with clinical outcome. Six of eight patients, where &gt;20% of the cells in G0/G1 were positive for topo IIalpha, entered CR, compared to one of five patients with &lt;20% topo IIalpha positive cells in G0/G1. We suggest that topo IIalpha expression in G0/G1 in leukemic cells may be of predictive value for clinical response to cytostatic drugs.
  •  
70.
  • Villman, Kenneth, et al. (författare)
  • Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas
  • 2002
  • Ingår i: Modern Pathology. - Philadelphia, USA : Lippincott Williams & Wilkins. - 0893-3952. ; 15:5, s. 486-491
  • Tidskriftsartikel (refereegranskat)abstract
    • Topoisomerase II-alpha (topo II alpha) is the key target enzyme for the topoisomerase inhibitor class of anti-cancer drugs. In normal cells, topo II alpha is expressed predominantly in the S/G2/M phase of the cell cycle. In malignant cells, in vitro studies have indicated that the expression of topo II alpha is both higher and less dependent on proliferation state in the cell. We studied fresh specimens from 50 cases of primary breast cancer. The expression of topo II alpha in different cell cycle phases was analyzed with two-parameter flow cytometry using the monoclonal antibody SWT3D1 and propidium iodide staining. The expression of topo II alpha was significantly higher in the S/G2/M phase of the cell cycle than in the G0/G1 phase in both DNA diploid and DNA non-diploid tumors. In 18 of 21 diploid tumors, and in 25 of 29 non-diploid tumors, &gt;50% of the topo II alpha-positive cells were in the G0/G1 phase. This significant expression of topo II alpha in the G0/G1 phase of the cell cycle may have clinically important implications for treatment efficacy of topoisomerase II inhibitors.
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (241)
Typ av publikation
tidskriftsartikel (887)
doktorsavhandling (74)
konferensbidrag (22)
forskningsöversikt (20)
bokkapitel (12)
rapport (1)
visa fler...
annan publikation (1)
visa färre...
Typ av innehåll
refereegranskat (912)
övrigt vetenskapligt (145)
populärvet., debatt m.m. (1)
Författare/redaktör
Olsson, Håkan, (50)
Borg, Åke, (44)
Li, Xinjun, (33)
Fernö, Mårten, (30)
Mertens, Fredrik, (30)
Möller, Torgil, (28)
visa fler...
Bendahl, Pär Ola, (26)
Hemminki, K (22)
Baldetorp, Bo, (21)
Berglund, Göran, (21)
Landberg, Göran, (19)
Nilbert, Mef, (19)
Anderson, Harald (18)
Glimelius, Bengt, (17)
Larsson, Christer, (17)
Påhlman, Sven, (17)
Hemminki, Kari, (17)
Åkerman, Måns, (16)
Tennvall, Jan, (16)
Dillner, Joakim, (15)
Hultborn, Ragnar, 19 ... (14)
Svanberg, Katarina, (14)
Lennernäs, Bo, 1963- ... (14)
Alvegård, Thor, (14)
Dillner, J, (13)
Mertens, F, (13)
Axelson, Håkan (13)
Ahlman, Håkan, 1947- ... (13)
Strand, Sven-Erik, (13)
Gustafson, Pelle, (13)
Glimelius, B, (12)
Wängberg, Bo, 1953-, (12)
Ringnér, Markus, (12)
Stenram, Unne, (11)
Naredi, Peter, 1955- ... (11)
Manjer, Jonas, (11)
Svanberg, Sune, (11)
Mitelman, Felix, (11)
Rydholm, Anders, (11)
Karlsson, Mats G, 19 ... (11)
Blomqvist, Carl (10)
Andersson-Engels, St ... (10)
Nilsson, Ola, 1957-, (10)
Olsson, H., (10)
Mattsson, Sören, (10)
Hallmans, G (10)
Albertsson, Maria (10)
Härkönen, Pirkko, (10)
Janzon, Lars, (10)
Dictor, Michael, (10)
visa färre...
Lärosäte
Lunds universitet (706)
Göteborgs universitet (134)
Karolinska Institutet (117)
Uppsala universitet (79)
Umeå universitet (42)
Örebro universitet (27)
visa fler...
Linköpings universitet (22)
Stockholms universitet (9)
Södertörns högskola (3)
Kungliga Tekniska Högskolan (2)
Högskolan i Jönköping (2)
Chalmers tekniska högskola (2)
Högskolan i Halmstad (1)
Linnéuniversitetet (1)
Högskolan i Gävle (1)
Ersta Sköndal Bräcke högskola (1)
visa färre...
Språk
Engelska (1003)
Svenska (12)
Kinesiska (1)
Annat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (1017)
Naturvetenskap (10)
Teknik (2)
Samhällsvetenskap (1)
Humaniora (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy